海外の治験の状況「1」での検索結果
10032件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 地域
- 登録日
Not recruiting
- Phase II of AUY922 in Second-line Gastric Cancer in Combination With Trastuzumab in HER2 Positive Patients
- Advanced Gastric Cancer
- Belgium, France, Germany, Italy, Japan, Korea, Republic of, Netherlands, Spain, United States
- 2011-07-24
Not recruiting
- Assessing Cost and Effectiveness of Training and Supervision of Front Line Workers on Early Breastfeeding Practices
- Malnutrition
- Bangladesh
- 2011-06-30
Not recruiting
- HIV Attachment Inhibitor to Treat Human Immunodeficiency Virus 1 (HIV-1) Infections
- Infection, Human Immunodeficiency Virus;Infection, Human Immunodeficiency Virus;Infection, Human Immunodeficiency Virus
- Argentina, Colombia, Germany, Mexico, Peru, Romania, Russian Federation, South Africa, Spain, United States
- 2011-06-23
Not Recruiting
- The role of pigment epithelium-derived factor (PEDF) in sepsis
- Sepsis
- China
- 2011-04-27
Not recruiting
- First Line Study of Tamibarotene in Combination for Advanced Non-Small Cell Lung Cancer
- Stage IIIB Non-small Cell Lung Cancer With Pleural Effusion;Stage IV Non-small Cell Lung Cancer
- Bulgaria, India, Mexico, Russian Federation, Ukraine, United States
- 2011-04-15
Not recruiting
- Customizing First Line Chemotherapy in Advanced Non-Small Cell Lung Cancer
- Non-Small Cell Lung Cancer
- Saudi Arabia
- 2011-03-19
Recruiting
- An observational study to evaluate the safety and efficacy of FOLFIRI / FOLFOX plus Cetuximab as first-line therapy in patients with KRAS wild-type metastatic Colorectal cancer
- Patients with KRAS wild-type metastatic Colorectal cancer
- India
- 2011-02-24
Recruiting
- Pharmacogenomics Study of CPT-11 as the First-line Chemotherapy for mCRC
- Colorectal Cancer
- China
- 2011-01-24
Not recruiting
- Axitinib as Second-line Treatment for Advanced Hepatocellular Carcinoma
- Hepatocellular Carcinoma;Hepatocellular Carcinoma;Hepatocellular Carcinoma;Hepatocellular Carcinoma
- Taiwan
- 2011-01-06
Not Recruiting
- PENTA18: Pharmacokinetics, safety and efficacy of lopinavir/ritonavir tablets in combination antiretroviral therapy in human immunodeficiency virus-1 (HIV-1) infected children
- Infectious disease - Paediatric HIV Infections and Infestations Human immunodeficiency virus
- Austria, Belgium, Brazil, Denmark, Germany, Ireland, Italy, Netherlands, Poland, Spain, Sweden, Thailand, United Kingdom
- 2009-07-10
Not Recruiting
- Randomised comparative study of folfox6m plus SIR-Spheres microspheres versus folfox6m alone as first line treatment in patients with non-resectable liver metastases from primary colorectal carcinoma
- Non-resectable liver metastasis from primary colorectal carcinoma MedDRA version: 17.1 Level: LLT Classification code 10052362 Term: Metastatic colorectal cancer System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04];Non-resectable liver metastasis from primary colorectal carcinoma MedDRA version: 17.1 Level: LLT Classification code 10052362 Term: Metastatic colorectal cancer System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04];Non-resectable liver metastasis from primary colorectal carcinoma MedDRA version: 17.1 Level: LLT Classification code 10052362 Term: Metastatic colorectal cancer System Organ Class: 100000004864 ;Therapeutic area: Diseases [C] - Cancer [C04]
- Australia, Belgium, France, Germany, Israel, Italy, New Zealand, Spain, United States
- 2008-10-01
Recruiting
- Safety and Efficacy of Ginsenoside Rg3 in Combination With First-line Chemotherapy in Advanced Gastric Cancer
- Self Efficacy
- China
- 2012-12-21
Not Recruiting
- A Phase III, open-label, multicenter trial of avelumab (MSB0010718C) versus platinum-based doublet as a first-line treatment of recurrent or Stage IV PD-L1+ non–small-cell lung cancer
- -C34 Malignant neoplasm of bronchus and lung Malignant neoplasm of bronchus and lung;Malignant neoplasm of bronchus and lung
- Australia, Belgium, Bulgaria, Canada, Chile, Colombia, Croatia, Czech Republic, Denmark, Estonia, France, Germany, Hungary, Ireland, Israel, Italy, Japan, Korea South, Lithuania, Malasya, Mexico, Netherlands, New Zealand, Poland, Portugal, Romania, Russian Federation, Singapore, Slovakia, South Africa, Spain, Taiwan, Thailand, Turkey, United Kindgdom, United States
- 2016-05-16
Not recruiting
- Osimertinib in First and Second Line Treatment of NSCLC Harboring EGFR Mutations From Circulating Tumor DNA
- Lung Neoplasms;EGFR Gene Mutations
- Korea, Republic of
- 2016-05-09
Recruiting
- Metronomic Capecitabine Plus Aromatase Inhibitor for First Line Treatment in HR(+), Her2(-) Metastatic Breast Cancer
- Breast Cancer;Breast Cancer;Breast Cancer;Breast Cancer
- China
- 2016-05-07
Recruiting
- Apatinib Plus Docetaxel as 2nd Line Treatment in Patients With Advanced Non-squamous and Non-small Cell Lung Cancer
- Non-small Cell Lung Cancer
- China
- 2016-05-03
Not recruiting
- Clarithromycin Triple Therapy Plus Bismuth for Helicobacter Pylori First-line Treatment
- Helicobacter Pylori Infection
- China
- 2016-04-04
Recruiting
- A Study of Second-line Treatment With Apatinib After TACE in Advanced Hepatocellular Carcinoma Patients
- Hepatocellular Carcinoma
- China
- 2016-03-28
Recruiting
- Effect of Dexmedetomidine on POCD and the expression of HMGB1, RAGEmRNA in peripheral blood in eldly hip or knee replacement surgery patients
- postoperative cognitive dysfunction
- China
- 2016-03-20
Recruiting
- Apatinib as Second-line Treatment of Advanced Pancreatic Cancer
- Pancreatic Neoplasms
- China
- 2016-03-16
